The Mycotyrant Price

Updated 2026-05-06

The Mycotyrant foil is bleeding out after early hype collapsed the spec. Down -14.6% over seven days from a $1.92 peak, the mythic has shed -12.0% from its ceiling while clawing back just +6.3% from the $1.59 trough, signaling sellers are winning the intraday battle. The -2.3% monthly decline masks violent recent action: this card spiked early, drew aggressive entry, then faced sustained liquidation as the broader market reassessed. Current $1.69 pricing sits closer to capitulation lows than the initial euphoria, which suggests either the hype case was overblown or demand fundamentals never materialized beyond the initial chase window. Lost Caverns supply likely isn't constraining the downside here. Watch whether the card finds a floor at current levels or cracks below $1.59 next; a sustained hold above $1.65 would suggest diamond hands are catching falling knives, but sustained breaks lower indicate serious bag holder territory.